Common Contracts
5 similar Underwriting Agreement contracts by AMERI Holdings, Inc., Applied Dna Sciences Inc, China Hydroelectric Corp, Mabvax Therapeutics Holdings, Inc.
FORM OF UNDERWRITING AGREEMENT [ Ÿ ] Shares [ Ÿ ] Warrants to Purchase Shares1 Ameri Holdings, Inc. Common Stock, par value $0.01 per share UNDERWRITING AGREEMENTUnderwriting Agreement • November 8th, 2017 • AMERI Holdings, Inc. • Semiconductors & related devices • New York
FORM OF UNDERWRITING AGREEMENT [ Ÿ ] Shares [ Ÿ ] Warrants to Purchase Shares1 Ameri Holdings, Inc. Common Stock, par value $0.01 per share UNDERWRITING AGREEMENTUnderwriting Agreement • November 6th, 2017 • AMERI Holdings, Inc. • Semiconductors & related devices • New York
Shares of Common Stock and [_____________] Warrants to Purchase an Aggregate of [_____________] Shares of Common Stock MABVAX THERAPEUTICS HOLDINGS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • August 25th, 2015 • Mabvax Therapeutics Holdings, Inc. • Pharmaceutical preparations • New York
MabVax Therapeutics Holdings, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions contained in this agreement (this “Agreement”), to sell to you and the other underwriters named on Schedule I hereto (collectively, the “Underwriters”), for whom you are acting as Representative (the “Representative”), an aggregate of [___________] shares (the “Firm Shares”) of the Company’s common stock, $0.01 par value per share (the “Common Stock”). For every two Firm Shares issued and sold by the Company, the Company shall issue and sell to the several Underwriters one warrant to purchase one share of Common Stock at an initial exercise price of $[___] per share ([__]% of the public offering price per Firm Share in the offering), subject to adjustment as provided therein (each, a “Warrant” and collectively, the “Warrants”), or an aggregate of [________] Warrants to purchase an aggregate of [______] shares of Common Stock (the “Firm Warrants” and together with th
3,820,000 Shares of Common Stock and 1,528,000 Warrants to Purchase Shares of Common Stock APPLIED DNA SCIENCES, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • March 27th, 2015 • Applied Dna Sciences Inc • Services-miscellaneous business services • New York
Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions contained herein, (this “Agreement”), to sell to you and the other underwriters named on Schedule I to this Agreement (the “Underwriters”), for whom Maxim Group LLC (“Maxim”) is acting as Representative (the “Representative,” “you” or similar terminology), an aggregate of 3,820,000 shares of the Company’s common stock, $0.001 par value per share (the “Common Stock” and 1,528,000 warrants (the “Warrants”) with the right to purchase one share of Common Stock at an exercise price of $3.50 per share (together, “Securities”). The respective numbers of Securities to be purchased by each of the several Underwriters are set forth opposite their names on Schedule I hereto. In addition, the Company proposes to grant to the Underwriters an option to purchase up to an additional 573,000 shares of Common Stock (the “Option Shares”) and/or up to an additional 229,200 Warrants (the “Optio
Units CHINA HYDROELECTRIC CORPORATION UNDERWRITING AGREEMENT January [ ], 2010Underwriting Agreement • January 19th, 2010 • China Hydroelectric Corp • Electric services • New York
